Frequently asked questions about NextGen GTN™
What is NextGen GTN™?
NextGen GTN™ is a Gross-to-Net education platform and commercialization intelligence framework built around the Patients + Profitability™ philosophy. It teaches commercial, market access, patient services, government pricing and finance teams how their decisions become the Gross-to-Net number, so the number can be managed where it is created rather than explained at quarter end.
Why does the Gross-to-Net number miss?
Because it goes wrong in the assumptions, not the calculations. Commercial, Government Pricing and Finance each hold one piece of the same event. Finance is right that the accrual moved, Market Access is right that the contract was the best available, Trade is right that the channel performed as designed, and the number still misses. Nobody holds the whole thing.
Who is NextGen GTN™ for?
Leaders and teams in Commercial, Brand, Market Access, Patient Services, Trade and Distribution, Government Pricing and Finance who each own one piece of the patient journey and need a shared understanding of how their piece shows up in the Gross-to-Net number.
What programs does NextGen GTN™ offer?
The Two Sides of the Vinyl™, an eighteen-session curriculum in three perspectives (Side A Patients™, Side B Profitability™ and The 12" EP Pricing™); Alignment Labs™, four facilitated executive sessions that take a new product launch from an unformed commercial position to a launch execution plan; the Knowledge Library of articles and field guides; and the Knowledge Center of eBooks and playbooks.
Who created NextGen GTN™?
Patrick R. Coyle. He previously served as Vice President and Chief Financial Officer of Eisai Americas, led Gross-to-Net practice areas at two global advisory firms, and held senior finance and commercial roles at Novartis, Insmed and Bayer. He also created the Patients + Profitability™ philosophy the curriculum rests on.
